期刊文献+

我国新药审评项目管理影响因素研究 被引量:1

On Influencing Factors of New Drug Evaluation Project Management in China
下载PDF
导出
摘要 目的:提取和筛选出我国新药审评项目管理的影响因素,为我国药品监管部门建立新药审评项目管理模式提供参考。方法:运用项目管理理论、文献研究法,提取我国新药审评项目管理影响因素,并通过问卷调查法和因子分析法建立我国新药审评项目管理影响因素指标体系,并对指标体系重要性进行评估和权重分析。结果:在二级指标上的权重排序是药品审评项目计划管理>审评时限管理>药品审评项目团队组织结构>项目管理人的能力>药品审评项目过程管理>项目管理人的职权>药品审评质量管理。在三级指标上,细化审评流程、选择合适的项目管理人和建立完善的药品审评质量评价体系是影响最大的因素。结论:在审评项目启动前,首先,要细化审评流程,制定审评计划,审评计划的制定是明确审评目标和在规定时限完成的前提;其次,选择合适的项目管理人,保证沟通和信息的高效流通;最后,进一步完善药品审评质量管理,保证审评质量和效率。 Objective:To establish the management mode of new drug review project management for the medical products authorities in China by the analysis of the influencing factors of China’s new drug review project management.Methods:The key influencing factors of the project management of drug review in China were obtained by using project management theory and literature retrieval method.The index system of influence factors of drug review project management was established by questionnaire survey and factor analysis method,and was applied to the evaluation of the index system importance and weight analysis.Results:The weighting sequences on the secondary indicators were drug review project plan management>drug review project time limit management>drug review project organization structure>capacity of the project manager>drug review project process management>the authority of the project manager>drugs review quality management.On the third-level indicators,detailed review process,appropriate project managers and establishment of a sound drug evaluation quality system were the most influencing factors.Conclusion:Firstly,before the review project was launched,it was necessary to detail the review process and develop a review plan.The review plan was developed to clarify the objectives of the review and the prerequisites for completion within the specified time.Secondly,an appropriate project manager was selected to ensure efficient communication and information.Finally,the quality management of drug reviews was further improved to ensure review quality and efficiency.
作者 任爽 董凌云 张象麟 Ren Shuang;Dong Lingyun;Zhang Xianglin(College of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China;Beijing Yeedozencom Healthcare Science&Technology Co.Ltd.,Beijing 100055,China)
出处 《中国药事》 CAS 2020年第3期288-297,共10页 Chinese Pharmaceutical Affairs
关键词 新药审评 项目管理 影响因素 因子分析法 drug evaluation project management influencing factors factor analysis
  • 相关文献

参考文献5

二级参考文献12

  • 1任海,王凯珍,肖淑红,赵书祥,陈国强.论体育资源配置模式——社会经济条件变革下的中国体育改革(一)[J].天津体育学院学报,2001,16(2):1-5. 被引量:184
  • 2国家食品药品监督管理局.国食药监注[2009]17号“关于印发新药注册特殊审批管理规定的通知”[S].2009.
  • 3FDA. Guidance for Industry[ S]. Formal Meetings with Sponsors and Applicants for PDUFA Products. 2000.
  • 4国家食品药品监督管理局药品审评中心.特殊审批品种沟通交流工作机制实施细则[EB/OL].(2009-03-02).http://www.cde.org.cn/特殊审批程序/特殊审批程序实施细则.
  • 5国家食品药品监督管理局药品审评中心.特殊审批品种沟通交流会会议纪要撰写格式[EB/OL].(2009-03-02).http://www.cde.org.cn/特殊审批程序/特殊审批程序实施细则.
  • 6CMR International,Workshop Review:Buiding Quality Measures into the Regulatory Review Process: Assessing the Needs of Industry and Regulators,Edited by Carolyn Hynes, Neil McAuslane, Stuart Walker,2002
  • 7http://www.cmr.org
  • 8关信平.社会研究方法[M]高等教育出版社,2004.
  • 9刘朝杰.问卷的信度与效度评价[J].中国慢性病预防与控制,1997,5(4):174-177. 被引量:214
  • 10巫秀美,倪宗瓒.因子分析在问卷调查中信度效度评价的应用[J].中国慢性病预防与控制,1998,6(1):28-31. 被引量:60

共引文献840

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部